UK small-cap RNS · 16 Apr 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 07:00 | Audioboom Group BOOM | £85m | Trading update | Q1 Trading Update
Record Q1: 30% Revenue Growth and 118% adjusted EBITDA Growth |
|
| 07:00 | NARF Industries NARF | £4.5m | Trading update | Trading Update and New Contract Win
Revenue growth and strengthened FY27 visibility; initial Ranger.ai contract |
|
| 07:00 | eEnergy Group EAAS | £1.1m | Dilutive fundraise | Q1 Trading Update, Revenue Recognition & Outlook
FY26 outlook: A step-change in scale and earnings |
|
| 07:00 | Alumasc Group ALU | £83m | Transformational contract / build-out | Q3 Trading Update
Alumasc (ALU.L), the premium sustainable building products, systems and solutions Group, provides the following trading update for the third quarter of its financial year ending 30 June 2026 ('Q3 FY25/26' or 'the period'). |
|
| 07:00 | Dunelm Group DNLM | £1,727m | Upgrade / downgrade cycle | Third quarter trading update
Sales growth and continued strong gross margin despite uncertain environment |
|
| 07:00 | Hays HAS | £938m | Trading update | Third Quarter Trading Statement
Hays plc ('Hays' or the 'Company') today announces its quarterly update for the three months ended 31 March 2026 ('Third Quarter Trading Statement'), which is available at: http://www.rns-pdf.londonstockexchange.com/rns/6571A_1-2026-4-15.pdf. |
|
| 07:00 | Ashmore Group ASHM | £1,442m | Trading update | Trading Statement
Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ending 31 March 2026. |
|
| 07:00 | Verici DX VRCI | £8.9m | Trading update | Positive Q1 Trading Update
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, provides a trading update demonstrating strong momentum for the three months ended 31 March 2026 (Q1 '26). |